BusinessVBI Vaccines Strengthens Board of Directors with Appointment of Ran NussbaumBy Nasdaq OMXNov 2, 2017, 12:02 PM UTC
BusinessVBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common SharesBy Nasdaq OMXOct 31, 2017, 12:31 PM UTC
BusinessVBI Vaccines Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Upsized Registered Direct Offering for Aggregate Proceeds of $71.9 MillionBy Nasdaq OMXOct 30, 2017, 12:01 PM UTC
BusinessVBI Vaccines Prices Concurrent Public Offering and Registered Direct Offering for Aggregate Proceeds of $63.5 MillionBy Nasdaq OMXOct 26, 2017, 1:29 PM UTC
BusinessBeyondSpring Announces the First Patient Enrolled in China in its Global Phase 2/3 Trial with Plinabulin for the Prevention of Chemotherapy-Induced NeutropeniaBy Nasdaq OMXOct 26, 2017, 12:31 PM UTC
BusinessVBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common SharesBy Nasdaq OMXOct 25, 2017, 8:01 PM UTC
BusinessBeyondSpring Receives Two Grants in China to Further Develop Innovative Drug PipelineBy Nasdaq OMXOct 23, 2017, 12:31 PM UTC
BusinessBeyondSpring Chief Medical Officer to Present at the 2017 BIO Investor Forum on Oct. 18 in San FranciscoBy Nasdaq OMXOct 18, 2017, 12:30 PM UTC
